ArticleFrontiers in immunology2019

Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation.

Mohammed O Abdelaziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.